전기생리학적 매핑 및 절제 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 제품 커버리지별, 지역별, 부문별 예측(2026-2033년)
Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type, By Product Coverage, By Region, And Segment Forecasts, 2026 - 2033
상품코드
:
1941536
리서치사
:
Grand View Research
발행일
:
2026년 01월
페이지 정보
:
영문 150 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
전기생리학적 매핑 및 절제 기기 시장 요약
세계의 전기생리학적 매핑 및 절제 기기 시장 규모는 2025년에 308억 9,000만 달러로 추정되며, 2033년까지 626억 1,000만 달러에 달할 것으로 예측됩니다.
2026년부터 2033년까지 CAGR 8.2%로 성장할 것으로 예상됩니다. 복잡한 부정맥, 특히 심방세동 진단 및 치료에서 전기생리학적(EP) 매핑 및 절제 기기의 채택 확대가 시장 성장의 주요 촉진요인으로 작용하고 있습니다.
병원 및 외래 진료 환경에서 첨단 리듬 관리 도구에 대한 수요 증가와 더불어 좌식 생활, 흡연, 음주로 인한 젊은 층의 심장 질환 부담 증가로 인해 기기 사용이 가속화되고 있습니다. 존슨앤드존슨 서비스(Johnson & Johnson Service)의 2024년 2월 발표에 따르면, 전 세계적으로 3,750만 명 이상이 심방세동의 영향을 받고 있습니다. 40세 이상 성인 4명 중 1명은 평생 동안 이 질환에 걸릴 것으로 예상됩니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 세계의 전기생리학적 매핑 및 절제 기기 시장 변수, 동향, 범위
제4장 세계의 전기생리학적 매핑 및 절제 기기 시장 세분화 : 시술 유형별, 2021-2033년
제5장 세계의 전기생리학적 매핑 및 절제 기기 시장 세분화 : 제품 커버리지별, 2021-2033년(수량)(단위당 평균판매가격)
제6장 전기생리학적 매핑 및 절제 기기 시장 세분화, 지역별, 2021-2033년
제7장 경쟁 구도
KSM
영문 목차
Electrophysiology Mapping And Ablation Devices Market Summary
he global electrophysiology mapping and ablation devices market size was estimated at USD 30.89 billion in 2025 and is projected to reach USD 62.61 billion by 2033, growing at a CAGR of 8.2% from 2026 to 2033. Growing adoption of electrophysiology (EP) mapping and ablation devices for the diagnosis and treatment of complex arrhythmias, particularly atrial fibrillation, is a key driver of market growth.
Rising demand for advanced rhythm management tools in both hospital and ambulatory settings, coupled with the increasing burden of cardiac conditions among younger populations due to sedentary lifestyles, smoking, and alcohol use, is accelerating device utilization.According to a February 2024 article by Johnson & Johnson Services, Inc., over 37.5 million people globally are affected by atrial fibrillation. Roughly 1 in 4 adults over 40 is projected to develop the condition during their lifetime.
Global Electrophysiology Mapping And Ablation Devices Market Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. for this study, Grand View Research has segmented the global electrophysiology mapping and ablation devices market report based on procedure type, product coverage, and region:
Procedure Type Outlook (In Thousands, 2021 - 2033)
EP Ablation Procedures
By Indication
Atrial Fibrillation
Paroxysmal AF
Persistent AF
Long standing persistent/permanent
Right Atrial Flutter
Left Atrial Flutter
Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Right Atrial Tachycardia (AT)
Left Atrial Tachycardia (AT)
Right Wolff-Parkinson-White (WPW)
Left Wolff-Parkinson-White (WPW)
Right Ventricular Tachycardia (VT)
Left Ventricular Tachycardia (VT)
Stand-Alone EP Diagnostic Procedures
By Product Type
Focal Ablation Catheter
Radiofrequency (RF)
Conventional
Irrigated-tip
Contact-Force-Sensing
Standard
Alternative Energy
Pulsed Field Ablation
Balloon Ablation Catheters
Product Coverage Outlook (Market Value (USD Million), Unit Sold, ASP Per unit (USD), 2021-2033)
Mapping & Lab Systems
X-Ray Systems
Mapping Systems
EP Recording Systems
ICE Systems
RF Ablation Generators
Pulsed Field Ablation Generators
Cryoablation Generators
Diagnostic Catheters
Conventional
Fixed
Steerable
Advanced
Ultrasound
Ablation Catheters
Focal Ablation Catheter
Radiofrequency (RF)
Conventional
Irrigated-tip
Contact-Force-Sensing
Standard
Alternative Energy
Pulsed Field Ablation
Balloon Ablation Catheters
Accessory Devices
Long Introducer Sheaths
Fixed
Steerable
Transseptal Needles
Conventional
RF
Navigational Accessories
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis (Model I)
1.6.2. Epidemiology/Volume Price Analysis (Model II)
1.6.3. Parent Market Analysis (Model III)
1.6.3.1. Research Scope and Assumptions
1.6.3.2. Research Methodology and Assumptions
1.6.3.3. Projecting The PFA & Other Electrophysiology Product Revenues For 2025
1.6.3.4. Insights Gained from Practitioners
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Segment Snapshot, by Product
2.2.2. Segment Snapshot, by Mapping & Lab Systems
2.2.3. Segment Snapshot, by Diagnostic Catheters
2.2.4. Segment Snapshot, by Ablation Catheters
2.2.5. Segment Snapshot, by Accessory Devices
2.3. Competitive Insights
Chapter 3. Global Electrophysiology (EP) Mapping and Ablation Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing Prevalence of Arrhythmia
3.2.1.2. Technological Advancements
3.2.1.3. Increasing Awareness and Screening Programs
3.2.2. Market restraint analysis
3.2.2.1. High Cost Associated with The Devices and Procedures
3.2.2.2. Regulatory Compliance
3.3. Comparative Analysis: Features, Advantages, And Benefits Analysis for PFA
3.3.1. Cryo VS PFA
3.3.2. RF VS PFA
3.3.3. PFA Vs Current Treatment Modalities
3.3.4. Potential Market Coverage
3.4. Global Electrophysiology (EP) Mapping and Ablation Devices: Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.2. PESTLE Analysis
3.5. Technological Advancements
3.5.1. Existing Technologies
3.5.2. Advanced Technologies
3.6. Pulsed Field Ablation (PFA) Analysis, By Company
3.6.1. Medtronic's PFA Systems
3.6.1.1. PulseSelect (PULSED AF IDE)
3.6.1.2. Sphere-360 (Affera single-shot PFA)
3.6.2. Johnson & Johnson PFA Systems (Varipulse PFA catheter)
3.6.3. Abbott Volt PFA System
3.6.4. Boston Scientific PFA System
Chapter 4. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Procedure Type, 2021 - 2033 (In Thousands)
4.1. Definition and Scope
4.2. Procedure Type Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Procedure Type, 2021 to 2033
(*) The chapter will include the following:
Procedure Volume, 2021 - 2033
Growth Rates (% CAGR)
Data split by:
Global Total
Regions (NA, Europe, APAC, Latin America, MEA)
Individual countries (as listed in Chapter 6)
4.5. EP Ablation Procedures
4.5.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.2. By Indication
4.5.3. Atrial Fibrillation
4.5.3.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.3.2. Paroxysmal AF
4.5.3.2.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.3.3. Persistent AF
4.5.3.3.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.3.4. Long standing persistent/permanent
4.5.3.4.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.4. Right Atrial Flutter
4.5.4.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.5. Left Atrial Flutter
4.5.5.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
4.5.6.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.7. Right Atrial Tachycardia (AT)
4.5.7.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.8. Left Atrial Tachycardia (AT)
4.5.8.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.9. Right Wolff-Parkinson-White (WPW)
4.5.9.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.10. Left Wolff-Parkinson-White (WPW)
4.5.10.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.11. Right Ventricular Tachycardia (VT)
4.5.11.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.12. Left Ventricular Tachycardia (VT)
4.5.12.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13. By Product Type
4.5.13.1. Focal ablation catheter
4.5.13.1.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.2. Radiofrequency (RF)
4.5.13.1.2.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.2.2. Conventional
4.5.13.1.2.2.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.2.3. Irrigated-tip
4.5.13.1.2.3.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.2.3.2. Contact-force-sensing
4.5.13.1.2.3.2.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.2.3.3. Standard
4.5.13.1.2.3.3.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.3. Alternative energy
4.5.13.1.3.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.1.4. Pulsed field ablation
4.5.13.1.4.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.5.13.2. Balloon ablation catheters
4.5.13.2.1. Market estimates and forecast 2021 - 2033, (In Thousand)
4.6. Stand-Alone EP Diagnostic Procedures
4.6.1. Market estimates and forecast 2021 - 2033, (In Thousand)
Chapter 5. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Product Coverage, 2021 - 2033 (USD Million) (Unit Sold/Volume) (ASP Per unit)
5.1. Definition and Scope
5.2. Product Coverage Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Product Coverage, 2021 to 2033
(*) The chapter will include the following:
Unit Sold, ASP Per unit (USD), Market Value (USD Million), 2021 - 2033
Growth Rates (% CAGR)
Data split by:
Global Total
Regions (NA, Europe, APAC, Latin America, MEA)
Individual countries (as listed in Chapter 6)
5.5. Mapping & Lab Systems
5.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.2. ASP trends estimates and forecast 2021 - 2033
5.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.4. X-Ray Systems
5.5.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.4.2. ASP trends estimate and forecast 2021 - 2033
5.5.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.5. Mapping Systems
5.5.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.5.2. ASP trends estimate and forecast 2021 - 2033
5.5.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.6. EP Recording Systems
5.5.6.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.6.2. ASP trends estimate and forecast 2021 - 2033
5.5.6.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.7. ICE Systems
5.5.7.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.7.2. ASP trends estimate and forecast 2021 - 2033
5.5.7.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.8. RF Ablation Generators
5.5.8.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.8.2. ASP trends estimate and forecast 2021 - 2033
5.5.8.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.9. Pulsed Field Ablation Generators
5.5.9.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.9.2. ASP trends estimate and forecast 2021 - 2033
5.5.9.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.5.10. Cryoablation Generators
5.5.10.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.5.10.2. ASP trends estimate and forecast 2021 - 2033
5.5.10.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.6. Diagnostic Catheters
5.6.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.2. ASP trends estimate and forecast 2021 - 2033
5.6.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.6.4. Conventional
5.6.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.4.2. Fixed
5.6.4.2.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.4.2.2. ASP trends estimate and forecast 2021 - 2033
5.6.4.2.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.6.4.3. Steerable
5.6.4.3.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.4.3.2. ASP trends estimate and forecast 2021 - 2033
5.6.4.3.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.6.5. Advanced
5.6.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.5.2. ASP trends estimate and forecast 2021 - 2033
5.6.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.6.6. Ultrasound
5.6.6.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.6.6.2. ASP trends estimate and forecast 2021 - 2033
5.6.6.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7. Ablation Catheters
5.7.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.2. ASP trends estimate and forecast 2021 - 2033
5.7.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4. Focal Ablation Catheter
5.7.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.4. Radiofrequency (RF)
5.7.4.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.4.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.4.4. Conventional
5.7.4.4.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.4.4.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.4.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.4.5. Irrigated-tip
5.7.4.4.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.4.5.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.4.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.4.5.4. Contact-force-sensing
5.7.4.4.5.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.4.5.4.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.4.5.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.4.5.5. Standard
5.7.4.4.5.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.4.5.5.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.4.5.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.5. Alternative energy
5.7.4.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.5.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.4.6. Pulsed field ablation
5.7.4.6.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.4.6.2. ASP trends estimate and forecast 2021 - 2033
5.7.4.6.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.7.5. Balloon Ablation Catheters
5.7.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.7.5.2. ASP trends estimate and forecast 2021 - 2033
5.7.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8. Accessory Devices
5.8.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.2. ASP trends estimate and forecast 2021 - 2033
5.8.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.4. Long Introducer Sheaths
5.8.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.4.2. ASP trends estimate and forecast 2021 - 2033
5.8.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.4.4. Fixed
5.8.4.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.4.4.2. ASP trends estimate and forecast 2021 - 2033
5.8.4.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.4.5. Steerable
5.8.4.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.4.5.2. ASP trends estimate and forecast 2021 - 2033
5.8.4.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.5. Transseptal Needles
5.8.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.5.2. ASP trends estimate and forecast 2021 - 2033
5.8.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.5.4. Conventional
5.8.5.4.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.5.4.2. ASP trends estimate and forecast 2021 - 2033
5.8.5.4.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.5.5. RF
5.8.5.5.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.5.5.2. ASP trends estimate and forecast 2021 - 2033
5.8.5.5.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
5.8.6. Navigational Accessories
5.8.6.1. Market estimates and forecast 2021 - 2033, (USD Million)
5.8.6.2. ASP trends estimate and forecast 2021 - 2033
5.8.6.3. Market estimates and forecast 2021 - 2033, (Unit Volume)
Chapter 6. Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)
(*) For each country/region, the final report will provide:
Market size & forecast
Growth Rates (% CAGR)
Competitive Scenario
Regulatory & reimbursement landscape
Dataset at each segment scope level as outlined in Chapters 4, and 5
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Electrophysiology (EP) Mapping and Ablation Devices Market Share by Region, 2025 & 2033:
6.5. North America
6.5.1. North America electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Scenario
6.5.2.3. Competitive Scenario
6.5.2.4. U.S. electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.2.4.1. ASP trends estimate and forecast 2021 - 2033
6.5.2.4.2. U.S. Market estimates and forecast 2021 - 2033, (Unit Volume)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Scenario
6.5.3.3. Competitive Scenario
6.5.3.4. Canada electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.3.4.1. ASP trends estimate and forecast 2021 - 2033
6.5.3.4.2. Canada Market estimates and forecast 2021 - 2033, (Unit Volume)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Scenario
6.5.4.3. Competitive Scenario
6.5.4.4. Mexico electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.4.4.1. ASP trends estimate and forecast 2021 - 2033
6.5.4.4.2. Mexico Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6. Europe
6.6.1. Europe electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Scenario
6.6.2.3. Competitive Scenario
6.6.2.4. UK electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.2.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.2.4.2. UK Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Scenario
6.6.3.3. Competitive Scenario
6.6.3.4. Germany electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.3.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.3.4.2. Germany Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Scenario
6.6.4.3. Competitive Scenario
6.6.4.4. France electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.4.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.4.4.2. France Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Scenario
6.6.5.3. Competitive Scenario
6.6.5.4. Italy electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.5.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.5.4.2. Italy Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Scenario
6.6.6.3. Competitive Scenario
6.6.6.4. Spain electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.6.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.6.4.2. Spain Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.7. Norway
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Scenario
6.6.7.3. Competitive Scenario
6.6.7.4. Norway electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.7.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.7.4.2. Norway Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Scenario
6.6.8.3. Competitive Scenario
6.6.8.4. Sweden electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.8.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.8.4.2. Sweden Market estimates and forecast 2021 - 2033, (Unit Volume)
6.6.9. Denmark
6.6.9.1. Key Country Dynamics
6.6.9.2. Regulatory Scenario
6.6.9.3. Competitive Scenario
6.6.9.4. Denmark electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.9.4.1. ASP trends estimate and forecast 2021 - 2033
6.6.9.4.2. Denmark Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Scenario
6.7.1.3. Competitive Scenario
6.7.1.4. Japan electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.1.4.1. ASP trends estimate and forecast 2021 - 2033
6.7.1.4.2. Japan Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Scenario
6.7.2.3. Competitive Scenario
6.7.2.4. China electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.2.4.1. ASP trends estimate and forecast 2021 - 2033
6.7.2.4.2. China Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Scenario
6.7.3.3. Competitive Scenario
6.7.3.4. India electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.3.4.1. ASP trends estimate and forecast 2021 - 2033
6.7.3.4.2. India Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Scenario
6.7.4.3. Competitive Scenario
6.7.4.4. Australia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.4.4.1. ASP trends estimate and forecast 2021 - 2033
6.7.4.4.2. Australia Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Scenario
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.5.4.1. South Korea ASP trends estimate and forecast 2021 - 2033
6.7.5.4.2. Market estimates and forecast 2021 - 2033, (Unit Volume)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Scenario
6.7.6.3. Competitive Scenario
6.7.6.4. Thailand electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.6.4.1. ASP trends estimate and forecast 2021 - 2033
6.7.6.4.2. Thailand Market estimates and forecast 2021 - 2033, (Unit Volume)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Scenario
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8.1.4.1. ASP trends estimate and forecast 2021 - 2033
6.8.1.4.2. Brazil Market estimates and forecast 2021 - 2033, (Unit Volume)
6.8.2. Argentina
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Scenario
6.8.2.3. Competitive Scenario
6.8.2.4. Argentina electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8.2.4.1. ASP trends estimate and forecast 2021 - 2033
6.8.2.4.2. Argentina Market estimates and forecast 2021 - 2033, (Unit Volume)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Scenario
6.9.1.3. Competitive Scenario
6.9.1.4. South Africa electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.1.4.1. ASP trends estimate and forecast 2021 - 2033
6.9.1.4.2. South Africa Market estimates and forecast 2021 - 2033, (Unit Volume)
6.9.2. Saudi Arabia
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Scenario
6.9.2.3. Competitive Scenario
6.9.2.4. Saudi Arabia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.2.4.1. ASP trends estimate and forecast 2021 - 2033
6.9.2.4.2. Saudi Arabia Market estimates and forecast 2021 - 2033, (Unit Volume)
6.9.3. UAE
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Scenario
6.9.3.3. Competitive Scenario
6.9.3.4. UAE electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.3.4.1. ASP trends estimate and forecast 2021 - 2033
6.9.3.4.2. UAE Market estimates and forecast 2021 - 2033, (Unit Volume)
6.9.4. Kuwait
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Scenario
6.9.4.3. Competitive Scenario
6.9.4.4. Kuwait electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.4.4.1. ASP trends estimate and forecast 2021 - 2033
6.9.4.4.2. Kuwait Market estimates and forecast 2021 - 2033, (Unit Volume)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis
7.3.1. Mapping & Lab Systems
7.3.1.1. Company Market Share Analysis: Regional
7.3.1.2. Company Market Share Analysis: North America
7.3.1.3. Company Market Share Analysis: Europe
7.3.1.4. Company Market Share Analysis: Asia Pacific
7.3.1.5. Company Market Share Analysis: Latin America
7.3.1.6. Company Market Share Analysis: Middle East & Africa
7.3.2. Diagnostic Catheters
7.3.2.1. Company Market Share Analysis: Regional
7.3.2.2. Company Market Share Analysis: North America
7.3.2.3. Company Market Share Analysis: Europe
7.3.2.4. Company Market Share Analysis: Asia Pacific
7.3.2.5. Company Market Share Analysis: Latin America
7.3.2.6. Company Market Share Analysis: Middle East & Africa
7.3.3. Ablation Catheters
7.3.3.1. Company Market Share Analysis: Regional
7.3.3.2. Company Market Share Analysis: North America
7.3.3.3. Company Market Share Analysis: Europe
7.3.3.4. Company Market Share Analysis: Asia Pacific
7.3.3.5. Company Market Share Analysis: Latin America
7.3.3.6. Company Market Share Analysis: Middle East & Africa
7.3.4. Accessory Devices
7.3.4.1. Company Market Share Analysis: Regional
7.3.4.2. Company Market Share Analysis: North America
7.3.4.3. Company Market Share Analysis: Europe
7.3.4.4. Company Market Share Analysis: Asia Pacific
7.3.4.5. Company Market Share Analysis: Latin America
7.3.4.6. Company Market Share Analysis: Middle East & Africa
7.4. Company Profiles
7.4.1. Siemens Healthineers
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Koninklijke Philips N.V.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Abbott
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Johnson & Johnson (Biosense Webster)
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. GE HealthCare
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Boston Scientific Corporation
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Medtronic
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Biotronik SE & Co KG
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. MicroPort Scientific Corporation
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. CardioFocus, Inc.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
관련자료